Jinhe Biotechnology Co., Ltd.
's Werelds grootste API-producent van chloortetracycline, die ook voorgemengde diervoederadditieven maakt.
Jinhe Biotechnology, genoteerd aan de Shenzhen Stock Exchange, is een wereldleider in op fermentatie gebaseerde diergezondheidsproducten. Het bedrijf produceert veterinaire actieve ingrediënten, antibiotica van diervoederkwaliteit en probiotica die worden verkocht aan diervoederfabrieken en distributeurs van diergezondheid in meer dan 80 landen. 60%+ exportratio.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Hohhot, China
- Website
- jinhebio.com
- Categories
- Veterinaire producten en diergezondheid, Diervoeder en ruwvoer
- Markets
- Verenigde Staten, Brazilië, India, Vietnam
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
- lei-lapsed (amber), checked 2026-08-12 GLEIF
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)